Trials / Recruiting
RecruitingNCT06718972
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
Database of Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Guangzhou Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a retrospective and prospective study planned to include NSCLC patients with Leptomeningeal metastasis (LM) and treated with antitumor therapy after 2018, from multiple centers such as the First Affiliated Hospital of Guangzhou Medical University, Guangdong Sanjiu Brain Hospital, etc., aiming to establish a database related to the treatment strategies of LM patients, and to evaluate the efficacy (eg. Overall Survival/Time to Failure) and safety of different treatment strategies of LM patients, etc., as well as the significance of concomitant testing in LM patients.
Detailed description
retrospective and prospective study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Not applicable- observational study | This is a retrospective and observational study. Not Applicable |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2024-12-05
- Last updated
- 2025-04-27
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06718972. Inclusion in this directory is not an endorsement.